Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

BusinessWeek January 16, 2006 Arlene Weintraub	Salmon That Grow Up Fast If Elliot Entis can win FDA approval for his quick-growing fish, he'll pave the way for other food companies working on genetically modified animals.
Science News March 6, 2004 Alexandra Goho	Fishy Alpha Males Lab experiments suggest that fish genetically modified to grow big fast could outcompete and thus threaten native fish in the wild.
Fast Company September 14, 2011 Margaret Rhodes	Transgenic Technology Meeting The FDA has yet to approve GM salmon for human consumption.
BusinessWeek July 14, 2003 Arlene Weintraub	The Outcry over "Terminator" Genes in Food Critics fear such safeguards present fresh genetic perils
Science News January 20, 2007 Julie J. Rehmeyer	Salmon Safety Scientific advice on the subject of how much salmon it is safe to eat has been confusing.
Wired May 2004 Charles C. Mann	The Bluewater Revolution The oceans of the world are being overfished. The solution: roaming robots that bring fish farming to the open seas. Aquaculture moves into deeper water.
Finefishing Saltwater Louis Bignami	Saving Salar Atlantic Salmon need our help
Science News February 4, 2006	Cyber Salmon To learn about the people of Alaska, several salmon species, and salmon habitat, try this Web site from the Alaska Region of the U.S. Fish and Wildlife Service.
BusinessWeek September 4, 2006	Restaurants "Should Know Better" Legal Sea Food CEO Roger Berkowitz discusses the need for conservation, aquaculture, and giving fish pretty names.
Seasoned Cooking October 2005 Robbin West	Sorting out Salmon Examine the major issues surrounding this fascinating and versatile fish, then learn how to fearlessly purchase it, prepare it and enjoy its healthful benefits.
BusinessWeek August 1, 2005	The Side Effects of Drugged Crops The Union of Concerned Scientists' Margaret Mellon explains the group's concerns about the dangers genetically altered food poses.
BusinessWeek September 4, 2006	Six Miles Out, Controversy In A Cage On an abandoned railroad pier off I-95 in Portsmouth, N.H., past mountainous stacks of rusting junk metal, Rich Langan's vision for the salvation of the American fishing industry slowly rises.
The Motley Fool December 31, 2007 Brian Lawler	The Anatomy Of An Approved Drug An independent audit by the FDA provides a useful summary of the characteristics of drugs approved by the agency.
The Motley Fool March 19, 2007 Brian Lawler	Is Dendreon Doomed? A pivotal FDA regulatory meeting approaches for the development-stage pharma. Investors, take note.
BusinessWeek September 3, 2007 John Carey	The Big Problem With Big Fish Feeble inspections make it easy for importers to slip through high-mercury seafood.
Nutrition Action Healthletter November 2001 David Schardt	Genetically Engineered Foods: Are They Safe? Using biotechnology to produce food has enormous potential: safer pesticides and less harm to wildlife, more nutritious foods, and greater yields to help feed the world's hungry nations. It's the risks of dicing and splicing Mother Nature that are harder to get a handle on...
BusinessWeek September 4, 2006 Aaron Pressman	Barramundi: The Next Big Fin? An Australian cousin of the over-fished Chilean sea bass is swimming to the rescue of diners - and perhaps U.S. fish farmers.
The Motley Fool April 11, 2008 Brian Lawler	Amgen's Unsurprising Delay The FDA extends its review of an Amgen drug candidate.
The Motley Fool March 23, 2007 Alyce Lomax	Is Monsanto Going to Seed? Several recent news headlines referring to its genetically modified products should give investors some reason to contemplate the risks that face this biotech giant.
BusinessWeek October 3, 2005 Geri Smith	Chile: An Innovative Incubator How did Chile, best known for its immense copper reserves, become the world's second-largest producer of salmon?
Prepared Foods February 6, 2007 Julia M. Gallo-Torres	Happy Feat According to a study published in a recent issue of Science, the world's supply of seafood could soon be gone. Will fish farming provide the solution?
BusinessWeek September 4, 2006 Aaron Pressman	Fished Out The U.S. fishing industry is sinking as the catch dwindles and a way of life vanishes. But a market-based fix could fill nets again.
The Motley Fool January 14, 2008 Brian Lawler	Score One for Dendreon and Disclosure A prestigious journal supports Dendreon's potential prostate cancer treatment, and makes a compelling case for more FDA disclosure.
Salon.com October 19, 2001 Katharine Mieszkowski	The genetically engineered pause that refreshes Corn chips and sodas are just two examples of today's "Frankenfoods," says the author of "Dinner at the New Gene Cafe"...
Food Engineering October 5, 2008 Kevin T. Higgins	Engineering R&D: A Real Fish Tale Years of research and industry involvement preceded the March launch of Michael Miller's fish-farming venture.
The Motley Fool December 31, 2010 Brian Orelli	2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions.
Seasoned Cooking August 2008 Philip R. Gantt	Phil's International Flair There are many ways to prepare salmon and this has become a favorite way to eat king salmon. Often found in Japanese restaurants, salmon sashimi has become a favorite with many.
The Motley Fool October 19, 2010 Brian Orelli	Why the FDA Won't Approve Lorcaserin and Qnexa (Yet) Obesity drugs get their day in front of the agency.
Pharmaceutical Executive January 1, 2006 Kenneth I. Kaitin	Opinion: Memo to von Eschenbach FDA's acting commissioner has an opportunity to clarify a lot of misconceptions about the agency's role in regulating drug safety. His first order of business should be to explain exactly what FDA doesn't do.
Food Processing January 2013 Dave Fusaro	2013 Food Industry Outlook: 5 Things to Look Out For In many ways, there's more optimism and fewer impediments than we've seen in the past couple of economically challenged years. But 2013 brings a new set of challenges, some the result of a return to growth - plus some perennial ones.
Wired October 2002 Todd Woody	The Plot to Kill the Carp Scientists are lab-testing a death fish that will wipe out its own species. Pests across the planet beware.
The Motley Fool February 16, 2010 Brian Orelli	For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward.
The Motley Fool January 31, 2007 Brian Lawler	FDA Says Hurray for More Drug Safety The FDA outlines its proposal to increase drug safety. Whatever the FDA does, pharmaceutical investors should hope that its renewed interest in drug safety doesn't make the already lengthy process of bringing drugs to market any longer.
Fast Company October 2008 Chip McCorkle	World Fisheries Congress Global seafood consumption has tripled during the past 50 years. At the fifth World Fisheries Congress in Yokohama, Japan, sustainability -- of the $155 billion industry and the animals it depends on -- will be the big concern. Here are seven species on the menu.
The Motley Fool December 22, 2003 Alyce Lomax	Losing Faith in Inspire Delay for its dry-eye treatment leaves investors uninspired.
The Motley Fool March 8, 2010 Brian Orelli	Really? A 59% Share Price Jump for That? Justified or not, InterMune skyrockets ahead of an FDA panel meeting.
The Motley Fool March 3, 2009 Brian Orelli	A Tale of 2 Weeks It's been a busy two weeks at Genzyme as two nasty notes from the FDA follow two approvals.
The Motley Fool November 27, 2006 Brian Lawler	Pharmaxis Gets Good News From the FDA Fast-track designation gives this pharmaceutical stock a bump.
The Motley Fool September 14, 2010 Luke Timmerman	Arena Obesity Drug Effective by "Slim Margin"; Shares Tumble The market is reacting negatively to news about the company's weight-loss drug.
IndustryWeek October 19, 2011	FDA: A Future Innovation Partner? Could the Food and Drug Administration reform itself to help manufacturers create new medical technologies?
AskMen.com Ross Bonander	Misconceived Green Movements Following is a list of five misconceived green movements, each of which emerged from honorable intentions, but wound up causing more damage -- either to the environment, to the movement itself or to us humans -- than it aimed to resolve.
Science News September 25, 2004 Janet Raloff	Omega-3's May Hit Food Labels The FDA will allow food manufacturers to make health claims for two omega-3 fatty acids, oils typically found in coldwater fish. Food labels can now note that products containing these oils might provide some protection from heart disease.
The Motley Fool April 29, 2008 Brian Orelli	Will These Drugs Get FDA Approval? Discovery Laboratories and Adolor are waiting FDA decisions on their drugs next month.
The Motley Fool August 17, 2007 Brian Orelli	Fewer Drug Approvals? Buy! Stricter standards at the FDA could create a buying opportunity. Drug approvals are down one third this year, creating a lot of value in pharmaceutical and biotech companies. Just choose your medicines carefully.
Food Processing June 2013 Butte & Whitesell	The FDA Must Define 'Natural' Soon 50 different state laws on labeling natural and genetically engineered foods would harm us all.
The Motley Fool September 9, 2010 Brian Orelli	Will These Drugs Get Past the FDA This Month? See what the FDA has on its decision calendar for the rest of September.
Geotimes November 2004 Sara Pratt	Fish Advisories on the Rise A new report from the Environmental Protection Agency shows an all-time high in the number of fish advisories that warn of contamination from toxins, including PCBs and mercury, despite a simultaneous decrease in U.S. emissions.
The Motley Fool November 14, 2007 Brian Lawler	Is the FDA Still Approving New Drugs? Lately the FDA seems more reluctant to approve new drugs than it once was. Let's take a look at the actual numbers from the past eight years.
Pharmaceutical Executive April 1, 2006 Jill Wechsler	Washington Report: A Warning Trend Washington's new answer to drug safety concerns is more warnings and more disclosure of undigested data. But warnings can go too far. Haven't FDA's critics ever heard the story of the boy who cried wolf?
Seasoned Cooking October 2007 Philip R. Gantt	Harvest Trout Fall is the time of the year when trout fishing is at its best in most regions of the country. Enjoy this harvest trout recipe whether you catch your own, or purchase it at a market.